Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation.

Hopewell S. et al, (2025), Ewha Med J, 48

Experiences of Using a Digital Text Messaging Intervention to Support Oral Medication Adherence for People Living With Type 2 Diabetes: Qualitative Process Evaluation.

Newhouse N. et al, (2025), J Med Internet Res, 27

Reducing inequalities through greater diversity in clinical trials - As important for medical devices as for drugs and therapeutics.

Roope LSJ. et al, (2025), Contemp Clin Trials Commun, 45

Clustering of Multimorbidity and Social Care Needs: 10-year all-cause mortality in a cohort study of more than 7 million people

Islam N. et al, (2025)

SPIRIT 2025 statement: updated guideline for protocols of randomized trials.

Chan A-W. et al, (2025), Nat Med

SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials.

Hróbjartsson A. et al, (2025), BMJ, 389

SPIRIT 2025 statement: updated guideline for protocols of randomised trials.

Chan A-W. et al, (2025), BMJ, 389

SPIRIT 2025 Statement: Updated Guideline for Protocols of Randomized Trials.

Chan A-W. et al, (2025), JAMA

CONSORT 2025 statement: updated guideline for reporting randomized trials.

Hopewell S. et al, (2025), Nat Med

CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials.

Hopewell S. et al, (2025), BMJ, 389

CONSORT 2025 statement: updated guideline for reporting randomised trials.

Hopewell S. et al, (2025), Lancet

CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials.

Hopewell S. et al, (2025), JAMA

CONSORT 2025 statement: updated guideline for reporting randomised trials.

Hopewell S. et al, (2025), BMJ, 389

CONSORT 2025 statement: Updated guideline for reporting randomised trials.

Hopewell S. et al, (2025), PLoS Med, 22

SPIRIT 2025 statement: Updated guideline for protocols of randomised trials.

Chan A-W. et al, (2025), PLoS Med, 22

The association of loneliness and social isolation with multimorbidity over 14 years in older adults in England: A population-based cohort study.

Hounkpatin H. et al, (2025), Arch Gerontol Geriatr, 131

A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study.

Dennis JM. et al, (2025), Lancet, 405, 701 - 714

Corrigendum to 'Remote Vital Sign Monitoring in Admission Avoidance Hospital at Home: A Systematic Review' [Journal of the American Medical Directors Association 25 (2024) 105080].

Patel R. et al, (2025), J Am Med Dir Assoc, 26

Implementation of evidence-based foot screening in people with diabetes: A scoping review.

Houghton JM. et al, (2025), J Diabetes Complications, 39

Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes.

Sammons E. et al, (2025), BMJ Open, 15

Load More

Include forthcoming?